CD274 and melanoma: The binding of PD1 on T cells and its ligand PD-L1 in tumor cells can induce the immune escape of tumor cells and exhaustion of T cells.[36] However, better clinical outcomes were also positively correlated with the expression level of PD-L1 on melanoma cells.